OTC drugs
GlaxoSmithKline Plc - OTC Healthcare World
| Publication Date | January 2008 |
| Publisher | Euromonitor International |
| Product Type | Report |
| Pages | 40 |
| ISBN Number | not applicable |
| Product Code | EUR00823 |
Price
£195.00
approximately: $295 | €218
approximately: $295 | €218
pdf immediate delivery
Order above formats by FAX
Summary
Euromonitor International's GlaxoSmithKline Plc Company Profile offers detailed strategic analysis of the company's business, examining its performance in the healthcare market. The report provides a strategic evaluation of the company, examines company shares by region and sector, offers a brand assessment and it addresses challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai and Vilniuis and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.
Contents
- Executive Summary
- Economic Growth Spurs Sales
- Eye Care Boosted by Growing Computer Usage
- Fragmented Shares LED by Multinationals
- Distribution Remains Fairly Limited
- Steady Growth Expected for Forecast Period
- Key Trends and Developments
- Introduction of Schedule K Amendments Promise Good Growth
- Retailers Play An Important Role in Dispensing Drugs
- Switch to Herbal Products from Standard
- Urbanisation and Busier Lifestyles Boost Sales
- Economic Growth Makes Healthcare More Affordable
- Territory Key Trends and Developments
- East and Northeast India
- North India
- South India
- West India
- Rural vs Urban Key Trends and Developments
- Market Indicators
- Market Data
- Appendix
- Otc Registration and Classification
- Vitamins and Dietary Supplements Registration and Classification
- Generics
- Consumer Expenditure on Health Goods and Medical Services
- Definitions
- Sources
- Local Company Profile - India
- Amrutanjan Ltd - Otc Healthcare - India
- Strategic Direction
- Key Facts
- Company Background
- Production
- Competitive Positioning
- Amway India Enterprises - Otc Healthcare - India
- Strategic Direction
- Key Facts
- Company Background
- Production
- Competitive Positioning
- Dabur India Ltd - Otc Healthcare - India
- Strategic Direction
- Key Facts
- Company Background
- Production
- Competitive Positioning
- Emami Ltd - Otc Healthcare - India
- Strategic Direction
- Key Facts
- Company Background
- Production
- Competitive Positioning
- Glaxosmithkline Pharmaceuticals (India) Ltd - Otc Healthcare - India
- Strategic Direction
- Key Facts
- Company Background
- Production
- Competitive Positioning
- Nicholas Piramal India Ltd - Otc Healthcare - India
- Strategic Direction
- Key Facts
- Company Background
- Production
- Competitive Positioning
- Paras Pharmaceuticals Ltd - Otc Healthcare - India
- Strategic Direction
- Key Facts
- Company Background
- Production
- Competitive Positioning
- Pfizer Ltd - Otc Healthcare - India
- Strategic Direction
- Key Facts
- Company Background
- Production
- Competitive Positioning
- Ranbaxy Laboratories Ltd - Otc Healthcare - India
- Strategic Direction
- Key Facts
- Company Background
- Production
- Competitive Positioning
- Cough, cold and allergy (hay fever) remedies in India
- Headlines
- Trends
- Competitive Landscape
- Prospects
- Sector Data
- Amrutanjan Ltd - Otc Healthcare - India
- List of Summaries
- Summary 1 Research Sources
- Summary 2 Amrutanjan Ltd: Key Facts
- Summary 3 Amrutanjan Ltd: Operational Indicators
- Summary 4 Amrutanjan Ltd: Production Statistics 2005-2006
- Summary 5 Amrutanjan Ltd: Competitive Position 2006
- Summary 6 Amway India Enterprises: Key Facts
- Summary 7 Amway India Enterprises: Operational Indicators
- Summary 8 Amway India Enterprises: Competitive Position 2006
- Summary 9 Dabur India Ltd: Key Facts
- Summary 10 Dabur India Ltd: Operational Indicators
- Summary 11 Dabur India Ltd: Production Statistics 2006
- Summary 12 Dabur India Ltd: Competitive Position 2006
- Summary 13 Emami Ltd: Key Facts
- Summary 14 Emami Ltd: Operational Indicators
- Summary 15 Emami Ltd: Production Statistics 2006
- Summary 16 Emami Ltd: Competitive Position 2006
- Summary 17 Glaxosmithkline Pharmaceuticals Ltd: Key Facts
- Summary 18 Glaxosmithkline Pharmaceuticals Ltd: Operational Indicators
- Summary 19 Glaxosmithkline Pharmaceuticals Ltd: Production Statistics 2005
- Summary 20 Glaxosmithkline Pharmaceuticals Ltd: Competitive Position 2006
- Summary 21 Nicholas Piramal India Ltd: Key Facts
- Summary 22 Nicholas Piramal India Ltd: Operational Indicators
- Summary 23 Nicholas Piramal India Ltd: Production Statistics 2006
- Summary 24 Nicholas Piramal India Ltd: Competitive Position 2006
- Summary 25 Paras Pharmaceuticals Ltd: Key Facts
- Summary 26 Paras Pharmaceuticals Ltd: Competitive Position 2006
- Summary 27 Pfizer Ltd: Key Facts
- Summary 28 Pfizer Ltd: Operational Indicators
- Summary 29 Pfizer Ltd: Production Statistics 2005
- Summary 30 Pfizer Ltd: Competitive Position 2006
- Summary 31 Ranbaxy Laboratories Ltd: Key Facts
- Summary 32 Ranbaxy Laboratories Ltd: Operational Indicators
- Summary 33 Ranbaxy Laboratories Ltd: Production Statistics 2005
- Summary 34 Ranbaxy Laboratories Ltd: Competitive Position 2006
- List of Tables
- Table 1 Life Expectancy at Birth 2001-2006
- Table 2 Sales of Otc Healthcare by Sector: Value 2001-2006
- Table 3 Sales of Otc Healthcare by Sector: % Value Growth 2001-2006
- Table 4 Sales of Otc Healthcare by Region: Value 2001-2006
- Table 5 Sales of Otc Healthcare by Region: % Value Growth 2001-2006
- Table 6 Sales of Otc Healthcare by Rural-Urban % Value Analysis 2006
- Table 7 Otc Healthcare Company Shares by Retail Value 2002-2006
- Table 8 Otc Healthcare Brand Shares by Retail Value 2003-2006
- Table 9 Sales of Otc Healthcare by Distribution Format: % Analysis 2001/2006
- Table 10 Sales of Otc Healthcare by Sector and Distribution Format: % Analysis 2006
- Table 11 Forecast Sales of Otc Healthcare by Sector: Value 2006-2011
- Table 12 Forecast Sales of Otc Healthcare by Sector: % Value Growth 2006-2011
- Table 13 Forecast Sales of Otc Healthcare by Region: Value 2006-2011
- Table 14 Forecast Sales of Otc Healthcare by Region: % Value Growth 2006-2011
- Table 15 Consumer Expenditure on Health Goods and Medical Services 2001-2006
- Table 16 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
- Table 17 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
- Table 18 Sales of Decongestants by Type: Value 2001-2006
- Table 19 Sales of Decongestants by Type: % Value Growth 2001-2006
- Table 20 Sales of Child-Specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
- Table 21 Sales of Child-Specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
- Table 22 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
- Table 23 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
- Table 24 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
- Table 25 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
- Table 26 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
